
Company Overview
Avalyn is reimagining the future of pulmonary fibrosis treatment with a pipeline of new inhaled formulations of approved medicines designed to reduce systemic exposure and deliver medication directly to the site of disease. Pulmonary fibrosis is characterized by scarring of lung tissue, decline in lung function, and reduced exercise capacity and quality of life, and is associated with increased mortality. Currently approved therapeutic options slow pulmonary fibrosis progression but are associated with significant toxicities that restrict their use and dosing. Avalyn’s inhaled approach tackles the underlying pathophysiology of pulmonary fibrosis at its source and is designed to reduce systemic exposure and deliver medication directly to the site of disease. Avalyn’s AP01 is an optimized inhaled formulation of pirfenidone, currently being studied in the ongoing MIST Phase 2b study in progressive pulmonary fibrosis (PPF). AP01 has been assessed in over 150 individuals with different forms of pulmonary fibrosis and demonstrated clinical proof-of-concept with improved efficacy and safety compared to historical data with existing therapies. The company completed two Phase 1 studies for AP02, inhaled nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF) and is planning a Phase 2 clinical trial. For more information, please visit avalynpharma.com and follow us on LinkedIn.
Position Summary
The Senior Manager / Associate Director, Regulatory Affairs will support the development and execution of the global regulatory strategy and execution for Avalyn’s development-stage, inhaled drug-device combination products. Reporting to the SVP, Regulatory Affairs, this position will oversee global regulatory submissions, health authority interactions, and cross-functional regulatory planning. This is a critical role for a highly motivated regulatory leader with experience in rare disease drug development, combination products, and a proven track record of advancing programs from early stages through late-phase clinical development.
In addition to leading regulatory activities for assigned development programs, the Senior Manager / Associate Director will contribute to regulatory initiatives that support consistency and operational excellence across the pipeline. This role will collaborate with senior regulatory leadership to strengthen processes, systems, and standards that enable efficient development and compliant global interactions. This position will play a key role in shaping the organization and operation of Avalyn’s regulatory function, ensuring high-quality systems, standards, and practices that enable efficient development, compliant execution, and successful global interactions with health authorities.
Key Responsibilities:
Strategic Leadership:
Regulatory Filings:
Health Authority Engagement:
Cross-Functional Collaboration:
Regulatory Intelligence & Compliance:
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.
Between 10 - 50 employees
2011
$436,679,488
Series D
$100,000,000 USD
Series C
$175,000,000 USD
Series B
$35,500,000 USD
Series A
$62,000,000 USD
Series A
$62,000,000 USD
Seed
$2,179,480 USD